Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012

Table 1 South African population by age groups exploring ARV treatment access. The HIV epidemiology of South Africa is described. The treatment shortfall represents those eligible for ART but unable to access it

Age groups	Population	Susceptible	Prevalence^a	On ARV treatment^a	Treatment shortfall^b
10–19	10 264 690	9 982 612	282 078	78 176	163 605
20–29	11 010 305	9 386 287	1 624 018	411 831	941 930
30–39	9 008 794	6 521 402	2 487 392	775 604	1 442 687
40–49	4 479 445	3 329 718	1 149 727	358 501	666 842
50–59	3 367 397	2 883 570	483 827	204 740	280 620
60+	3 665 571	3 534 983	130 588	55 260	75 741
Totals	41 796 202	35 638 572	6 157 630	1 884 112	3 571 425

^aShisana O et al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Cape Town, HSRC Press. 2014
^bUN Joint Program on HIV/AIDS (UNAIDS). The Gap Report. 2014

ISSN: 1471-2458